NCT05010629 2025-05-319-ING-41 Plus Carboplatin in Salivary Gland CarcinomaDana-Farber Cancer InstitutePhase 2 Active not recruiting35 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT04832438 2022-02-229-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland CarcinomaActuate Therapeutics Inc.Phase 2 Withdrawn
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT02124707 2020-08-12Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed14 enrolled 17 charts
NCT01166542 2014-11-05Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck CancersOncolytics BiotechPhase 3 Completed167 enrolled